Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional MR

ClinicalTrials.gov ID: NCT07227675

Public ClinicalTrials.gov record NCT07227675. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 10:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional MR Continued Access Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The COAPT Continued Access Study (CAS) is an extension of the COAPT RCT under the same IDE (G120024). COAPT CAS was a single-arm, prospective, multicenter continued access registry that enrolled heart failure patients with secondary mitral regurgitation who remained symptomatic despite optimal guideline-directed medical therapy (GDMT). The objective of the COAPT CAS is to continue the evaluation of safety and effectiveness of the MitraClip NT System under more "real world" conditions in patients who meet the COAPT inclusion/exclusion criteria and who have national Medicare coverage by the Centers for Medicare and Medicaid Services (CMS).

Study identification

NCT ID
NCT07227675
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Abbott Medical Devices
Industry
Enrollment
162 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 23, 2017 (Actual)
Primary completion
Mar 14, 2019 (Actual)
Completion
Mar 31, 2024 (Actual)
Last update posted
Nov 13, 2025

2017 – 2024

United States locations

U.S. sites
32
U.S. states
18
U.S. cities
28
Facility City State ZIP Site status
Scripps Green Hospital La Jolla California 92037 —
Cedars-Sinai Medical Center Los Angeles California 90048 —
El Camino Hospital Mountain View California 94040 —
Stanford Hospital and Clinics Stanford California 94305 —
University of Colorado Hospital Denver Colorado 80045 —
Mount Sinai Medical Center Miami Florida 33140 —
Tallahassee Memorial Hospital Tallahassee Florida 32308 —
Piedmont Hospital Atlanta Atlanta Georgia 30309 —
Northwestern Memorial Hospital Chicago Illinois 60611 —
Rush University Medical Center Chicago Illinois 60612 —
University of Maryland Medical Center Baltimore Maryland 21201 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Saint Luke's Hospital of Kansas City Kansas City Missouri 64111 —
Barnes Jewish Hospital St Louis Missouri 63110 —
Morristown Medical Center Morristown New Jersey 07960 —
NYU Langone Medical Center New York New York 10016 —
Columbia University Medical Center / New York Presbyterian Hospital New York New York 10032 —
St. Francis Hospital Roslyn New York 11576 —
Atrium Health Carolinas Medical Center Charlotte North Carolina 28203 —
Duke University Medical Center Durham North Carolina 27710 —
The Christ Hospital Cincinnati Ohio 45219 —
Cleveland Clinic Cleveland Ohio 44195 —
Oklahoma Heart Hospital Oklahoma City Oklahoma 73120 —
Providence St. Vincent Medical Center Portland Oregon 97225 —
Oregon Health and Science University Portland Oregon 97239 —
UPMC Presbyterian Pittsburgh Pennsylvania 15213 —
UPMC Shadyside Hospital Pittsburgh Pennsylvania 15232 —
Seton Medical Center Austin Austin Texas 78705 —
Baylor Heart and Vascular Hospital Dallas Texas 75204 —
The heart hospital baylor plano Plano Texas 75093 —
Intermountain Medical Center Murray Utah 84107 —
Virginia Commonwealth University Medical Center Richmond Virginia 23284 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07227675, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 13, 2025 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07227675 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →